These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14997275)

  • 21. Milnacipran inhibits glutamatergic N-methyl-D-aspartate receptor activity in spinal dorsal horn neurons.
    Kohno T; Kimura M; Sasaki M; Obata H; Amaya F; Saito S
    Mol Pain; 2012 Jun; 8():45. PubMed ID: 22716121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. General anesthetics have additive actions on three ligand gated ion channels.
    Jenkins A; Lobo IA; Gong D; Trudell JR; Solt K; Harris RA; Eger EI
    Anesth Analg; 2008 Aug; 107(2):486-93. PubMed ID: 18633027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oleamide potentiates benzodiazepine-sensitive gamma-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration.
    Yost CS; Hampson AJ; Leonoudakis D; Koblin DD; Bornheim LM; Gray AT
    Anesth Analg; 1998 Jun; 86(6):1294-300. PubMed ID: 9620523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emamectin is a non-selective allosteric activator of nicotinic acetylcholine receptors and GABAA/C receptors.
    Xu X; Sepich C; Lukas RJ; Zhu G; Chang Y
    Biochem Biophys Res Commun; 2016 May; 473(4):795-800. PubMed ID: 27049309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temperature: an important experimental variable in studying PKC modulation of ligand-gated ion channels.
    Machu TK; Dillon GH; Huang R; Lovinger DM; Leidenheimer NJ
    Brain Res; 2006 May; 1086(1):1-8. PubMed ID: 16626662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action.
    Bourin M; Masse F; Dailly E; Hascoët M
    Pharmacol Biochem Behav; 2005 Jul; 81(3):645-56. PubMed ID: 15961146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats.
    Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Tanaka T; Masui T; Koyama T
    Eur J Pharmacol; 2008 Apr; 584(2-3):285-90. PubMed ID: 18336812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nondepolarizing neuromuscular blockers inhibit the serotonin-type 3A receptor expressed in Xenopus oocytes.
    Min KT; Wu CL; Yang J
    Anesth Analg; 2000 Feb; 90(2):476-81. PubMed ID: 10648343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulations of quercetin and its glycosides on ligand-gated ion channels.
    Lee BH; Pyo MK; Lee JH; Choi SH; Shin TJ; Lee SM; Lim Y; Han YS; Paik HD; Cho SG; Yun-Choi HS; Rhim H; Nah SY
    Biol Pharm Bull; 2008 Apr; 31(4):611-7. PubMed ID: 18379051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Milnacipran, a serotonin and noradrenaline reuptake inhibitor, suppresses long-term potentiation in the rat hippocampal CA1 field via 5-HT1A receptors and alpha 1-adrenoceptors.
    Tachibana K; Matsumoto M; Togashi H; Kojima T; Morimoto Y; Kemmotsu O; Yoshioka M
    Neurosci Lett; 2004 Mar; 357(2):91-4. PubMed ID: 15036582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems.
    Tachibana K; Matsumoto M; Koseki H; Togashi H; Kojima T; Morimoto Y; Yoshioka M
    J Psychopharmacol; 2006 Jul; 20(4):562-9. PubMed ID: 16401668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ginsenosides regulate ligand-gated ion channels from the outside.
    Lee BH; Jeong SM; Ha TS; Park CS; Lee JH; Kim JH; Kim DH; Han JS; Kim HC; Ko SR; Nah SY
    Mol Cells; 2004 Aug; 18(1):115-21. PubMed ID: 15359132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct effects of the serotonin-noradrenaline reuptake inhibitors milnacipran and venlafaxine on rat pineal monoamines.
    Muneoka K; Kuwagata M; Ogawa T; Shioda S
    Neuroreport; 2015 Jun; 26(9):510-4. PubMed ID: 26016648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
    Solt K; Stevens RJ; Davies PA; Raines DE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran.
    Paris BL; Ogilvie BW; Scheinkoenig JA; Ndikum-Moffor F; Gibson R; Parkinson A
    Drug Metab Dispos; 2009 Oct; 37(10):2045-54. PubMed ID: 19608694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anesthetic mechanism of urethane: the effects on neurotransmitter-gated ion channels.
    Hara K; Harris RA
    Anesth Analg; 2002 Feb; 94(2):313-8, table of contents. PubMed ID: 11812690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats.
    Bel N; Artigas F
    Neuropsychopharmacology; 1999 Dec; 21(6):745-54. PubMed ID: 10633480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
    Vaishnavi SN; Nemeroff CB; Plott SJ; Rao SG; Kranzler J; Owens MJ
    Biol Psychiatry; 2004 Feb; 55(3):320-2. PubMed ID: 14744476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade and enhancement of glutamate receptor responses in Xenopus oocytes by methylated arsenicals.
    Krüger K; Gruner J; Madeja M; Hartmann LM; Hirner AV; Binding N; Musshoff U
    Arch Toxicol; 2006 Aug; 80(8):492-501. PubMed ID: 16474957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiemetics of the 5-hydroxytryptamine 3A antagonist class inhibit muscle nicotinic acetylcholine receptors.
    Paul M; Callahan R; Au J; Kindler CH; Yost CS
    Anesth Analg; 2005 Sep; 101(3):715-721. PubMed ID: 16115980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.